Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kailash Mosalpuria is active.

Publication


Featured researches published by Kailash Mosalpuria.


Journal of Oncology Practice | 2016

Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer

Daniel Almquist; Kailash Mosalpuria; Apar Kishor Ganti

Limited-stage small-cell lung cancer (SCLC) occurs in only one third of patients with SCLC, but it is potentially curable. Combined-modality therapy (chemotherapy and radiotherapy) has long been the mainstay of therapy for this condition, but more recent data suggest a role for surgery in early-stage disease. Prophylactic cranial irradiation seems to improve outcomes in patients who have responded to initial therapy. This review addresses the practical aspects of staging and treatment of patients with limited-stage SCLC.


Therapeutic Advances in Medical Oncology | 2015

Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National Cancer Data Base

Vijaya Raj Bhatt; Rajesh Shrestha; Jairam Krishnamurthy; Kailash Mosalpuria; Fausto R. Loberiza; Apar Kishor Ganti; Peter T. Silberstein

Background: The incidence of melanoma in older patients is on the rise. Prior studies have shown disparities in surgical management and poor survival of older patients with melanoma. Methods: This is a retrospective study of adult patients diagnosed with cutaneous invasive and in situ melanoma between 2000 and 2011 in the National Cancer Data Base. Characteristics and management of older patients (≥60 years) were compared with younger patients (20–59 years) using χ2 testing. Results: Of 476,623 total cases, 54% (n = 258,153) were diagnosed among older patients. The reported cases in the older patients increased by 1.74-fold between 2000 and 2011. The majority were white (96%), men (65%), with early-stage disease (76% stage 0-II), and superficial spreading melanoma histology (39%). Older patients, compared with younger patients, were more likely to be men (65% versus 49%, p < 0.0001), and have in situ melanoma (28% versus 21%, p < 0.0001); less likely to have nodal metastases (7% versus 9%, p < 0.0001), receive care in academic centers (30% versus 35%, p < 0.0001), undergo wide excision or major amputation for stage I–III disease (68% versus 72%, p < 0.0001) and systemic therapy for stage III (18% versus 45%, p < 0.0001) and IV disease (30% versus 50%, p < 0.0001). Conclusion: Older patients with melanoma are less likely to receive care in academic centers, undergo wide excision for stage I–III disease and receive systemic therapy for stage III–IV disease. Particularly, the utilization of systemic therapy is markedly low. This disparity is particularly important with the availability of less intense more effective therapies.


Journal of Community Hospital Internal Medicine Perspectives | 2014

A retrospective analysis of reported errata in five leading medical journals in 2012

Vijaya Raj Bhatt; Madan Raj Aryal; Sujana Panta; Kailash Mosalpuria; James O. Armitage

Background Although medical publications are frequently used as the source of information, the prevalence of errata remains unclear. The objective of this study was to examine peer-review and publication processes of medical journals as well as to determine the occurrence of reported errata in medical journals and timeliness in identifying and correcting errata. Methods Five medical journals, New England Journal of Medicine, Annals of Internal Medicine, British Medical Journal, Journal of American Medical Association, and Lancet, were evaluated. The characteristics of these journals were obtained from editors’ survey. All these journals report errata noted in their prior publications. We retrospectively analyzed all errata reported from January 1, 2012, to December 31, 2012. The mean number of reported errata per issue, the most common errata, and the mean time to report errata were calculated. Results The journals had high impact factors (14–51), received 3,200 to more than 15,000 submissions in 2012, and utilized two or more external reviewers and usually two or more editors for any accepted articles. All the journals edited the accepted articles, including references, figures, and tables for style. A mean of 1.3 articles with ≥1 errata was reported per issue (a total of 306 articles with errata in 226 issues). Errata in authors information, numeric errata, and errata in the figures and tables were the most common errata. The mean time to report the errata was 122 days. Conclusion The high-impact journals, with extensive pre-publication review, reported relatively few errata per issue. The delay in reporting errata needs further exploration.


Leukemia & Lymphoma | 2015

Splenectomy and second malignancies in patients with Hodgkin lymphoma: is there a causal relationship?

Kailash Mosalpuria; Fausto R. Loberiza


Journal of Clinical Oncology | 2017

Clinicopathologic characteristics and management trends of cutaneous melanoma among older patients: A National Cancer Data Base (NCDB) analysis.

Vijaya Raj Bhatt; Rajesh Shrestha; Jairam Krishnamurthy; Kailash Mosalpuria; Fausto R. Loberiza; Apar Kishor Ganti; Peter T. Silberstein


Journal of Clinical Oncology | 2017

A nonrandomized phase II study of dose-dense paclitaxel and cyclophosphamide (PC) in early-stage breast cancer (EBC).

Kailash Mosalpuria; Ryan C. Ramaekers; Mehmet Sitki Copur; Kenneth H. Cowan; Mary Mailliard; Elizabeth Lyden; Wajeeha Razaq; Elizabeth C. Reed


Journal of Clinical Oncology | 2017

Conditional survival estimates for lung cancer histologic subtypes in the U.S. (2004-2008).

Kailash Mosalpuria; Yan Xing; Chung-Yuan Hu; Vijaya Raj Bhatt; Apar Kishor Ganti


Journal of Clinical Oncology | 2017

Conditional survival estimates for small cell lung cancer receiving prophylactic cranial irradiation in the U.S. (1988-1997).

Yan Xing; Kailash Mosalpuria; Chung-Yuan Hu; Vijaya Raj Bhatt; Apar Kishor Ganti


World Journal of Hepatology | 2016

Clinical approach to diarrheal disorders in allogeneic hematopoietic stem cell transplant recipients

Shadi Hamdeh; Abd Almonem M. Abdelrahman; Osama Elsallabi; Ranjan Pathak; Smith Giri; Kailash Mosalpuria; Vijaya Raj Bhatt


Archive | 2016

Multimodality Therapy forLimited-Stage Small-Cell Lung Cancer

Daniel Almquist; Kailash Mosalpuria; Apar Kishor P Ganti

Collaboration


Dive into the Kailash Mosalpuria's collaboration.

Top Co-Authors

Avatar

Vijaya Raj Bhatt

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Apar Kishor Ganti

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Fausto R. Loberiza

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Peter T. Silberstein

Creighton University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Apar Kishor P Ganti

University of Nebraska–Lincoln

View shared research outputs
Top Co-Authors

Avatar

Daniel Almquist

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Jairam Krishnamurthy

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

James O. Armitage

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Lata Nawal

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar

Rajesh Shrestha

Memorial Hospital of Rhode Island

View shared research outputs
Researchain Logo
Decentralizing Knowledge